The epidermal growth factor receptor (EGFR), a member of the ErbB family of receptor tyrosine kinase (RTK), is frequently overexpressed in NSCLC and negatively correlated with poor prognosis (Barr Kumarakulasinghe et al., 2015; Hsu et al., 2019). Here, EGFR is linked to non-small cell lung carcinoma.